Seoul National University Airway Registry

Seoul National University Hospital800 enrolled

Overview

This is a multicenter, prospective observational cohort study, in which patients with chronic airway diseases including chronic obstructive pulmonary disease(COPD), asthma, asthma-COPD overlap syndrome (ACOS) will be recruited.

Study Type

OBSERVATIONAL

Enrollment

800

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Asthma Asthma With Chronic Obstructive Pulmonary Disease Bronchiectasis Inactive Tuberculosis of Lung Chronic Obstructive Airway Disease

Eligibility

Sex: ALLMin age: 20 YearsMax age: 90 Years

Medical Language ↔ Plain English

COPD Inclusion Criteria: * Postbronchodilator FEV1/FVC \< 0.7 AND chronic respiratory symptom Exclusion Criteria: \- Asthma Inclusion Criteria: * Never smoker or \<5PY of smoking history AND Recurrent episodes of asthma symptoms (wheezing, dyspnea, chest tightness, cough) AND (either Positive BDR OR positive metacholine/mannitol/exercise provocation test) Exclusion Criteria: \- ACOS Inclusion Criteria: * COPD AND Asthma (regardless of smoking status) Exclusion Criteria: \-

Locations (3)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

RECRUITING

Seoul National University Hospital

Seoul, South Korea

RECRUITING

Seoul Metropolitan Government-Seoul National University Boramae Medical Center

Seoul, South Korea

ACTIVE_NOT_RECRUITING

Outcomes

Primary Outcomes

Death (time to death)

death from any cause, death from COPD-specific cause, death from CVD, malignancy

Time frame: upto 20 years

Secondary Outcomes

post-bronchodilator FEV1 change rates

Time frame: upto 20 years (at least 3 years)